AZD8630

DB19397

biotech investigational

Deskripsi

AZD8630 is an experimental drug under investigation, as described in the Phase I clinical study titled "Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (NCT05110976)

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Target Protein

Thymic stromal lymphopoietin TSLP

Referensi & Sumber

Artikel (PubMed)
  • PMID: -
    Doffman S, Dosanjh D, Sadiq MW, Asimus S, Cooper J, Zhou X, Seth H, Pandya HC, Saralaya D, Beier J, Forsman H: Phase 1 Safety and Efficacy of AZD8630/AMG 104 Inhaled Anti-TSLP inHealthy Volunteers and Patients With Asthma on Medium-High DoseInhaled Corticosteroid (ICS) and Long-Acting Beta-agonist (LABA) WithElevated Baseline Fractional Exhaled Nitric Oxide (FeNO) .

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul